| Species | Disruptability | Reference | Submitter | |
|---|---|---|---|---|
| P. berghei ANKA |
Refractory |
RMgm-540 | Imported from RMgmDB | |
| P. berghei ANKA |
Refractory |
PlasmoGEM (Barseq) | PlasmoGEM | |
| P. berghei ANKA |
Possible |
RMgm-4677 | Imported from RMgmDB | |
| P. falciparum 3D7 |
Possible |
USF piggyBac screen (Insert. mut.) | USF PiggyBac Screen | |
| Species | Stage | Phenotype | Reference | Submitter |
|---|---|---|---|---|
| P. berghei ANKA | Asexual |
No difference |
RMgm-4677 | Imported from RMgmDB |
| P. berghei ANKA | Gametocyte |
No difference |
RMgm-4677 | Imported from RMgmDB |
| P. berghei ANKA | Ookinete |
No difference |
RMgm-4677 | Imported from RMgmDB |
| P. berghei ANKA | Oocyst |
No difference |
RMgm-4677 | Imported from RMgmDB |
| P. berghei ANKA | Sporozoite |
Difference from wild-type |
RMgm-4677
Normal sporozoite production. Pbstk2 KO sporozoites exhibit normal gliding motility, cell traversal activity, and infection of hepatocytes in vitro. |
Imported from RMgmDB |
| P. berghei ANKA | Liver |
Difference from wild-type |
RMgm-4677
Normal sporozoite production. Pbstk2 KO sporozoites exhibit normal gliding motility, cell traversal activity, and infection of hepatocytes in vitro. Prolonged prepatent period after infection of mice by intravenous injection of sporozoites. Evidence is presented for reduced hepatic schizogony and merozoite maturation (reduced MSP1 expression). |
Imported from RMgmDB |
| PlasmoDB | PBANKA_0311400 |
| GeneDB | PBANKA_0311400 |
| Malaria Metabolic Pathways | Localisation images Pathways mapped to |
| Previous ID(s) | PB000061.02.0, PB104395.00.0, PB405723.00.0, PBANKA_031140 |
| Orthologs | PCHAS_0313500 , PF3D7_0214600 , PKNH_0406200 , PVP01_0410300 , PVX_002805 , PY17X_0311900 |
| Google Scholar | Search for all mentions of this gene |